Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Shares of Halliburton Company (HAL - Analyst Report) are currently trading close to its 52-week low of $27.21. The oilfield services behemoth has seen its share price fall approximately 22% since the beginning of March this year, as investors have been selling the stock for its weak fundamentals and tepid outlook. A recent warning issued by the company about its second quarter profitability has added to this bearishness.
Houston, Texas-based Halliburton is one of the largest oilfield service providers in the world, offering a variety of equipment, maintenance and engineering and construction services to the energy, industrial and government sectors. The company operates under two main segments: Completion and Production, and Drilling and Evaluation.
Halliburton recently cautioned investors that a higher-than-expected spike in the cost for guar gums – a key constituent of the company’s market-leading ‘hydraulic fracturing’ procedure – will adversely impact its second quarter results.
Guar gum, a bean grown mostly in India, apart from being a dairy products thickener is also a main ingredient of the hydraulic fracturing (or fracking) process, which is used to extract natural gas by blasting underground rock formations with a mixture of water, sand and chemicals.
As per Halliburton, demand for guar gum has gone through the roof in North America following the growing use of hydraulic fracturing in the extraction of oil and natural gas liquids from shale. This has led to concerns about the commodity’s potential shortage later in 2012, thereby driving up guar gum prices more rapidly than previously thought.
The rising costs, according to the company, have affected its second quarter profitability in North America more than expected. The world's second-largest oilfield services firm after Schlumberger Ltd. (SLB - Analyst Report) now sees margins in the region to be down by 300 basis points more than the previous forecast of a 200–250 basis points squeeze, implying a 500–550 point drop from the first-quarter levels.
Additionally, the North American land rig count, which has experienced strong upward momentum over the last twelve months, may plateau in the near future as growth in highly-productive horizontal drilling has led to a natural gas supply overhang and relatively weak natural gas prices in the U.S. market. This is likely to be only partially offset by the continued growth of oil- and liquids-rich reservoirs. A slowdown in U.S. land drilling will adversely impact Halliburton’s business.
Lastly, we expect Halliburton shares to remain soft until it fully works its way through claims related to the Deepwater Horizon incident. We are also concerned by the slow and geographically uneven recovery in Halliburton’s international markets.
Given these concerns, we expect Halliburton to perform below its peers and industry levels in the coming months. As such, we see little reason for investors to own the stock. Our bearish investment thesis is supported by a Zacks #4 Rank (short-term Sell rating).
Partially offsetting these negatives are the company’s leading position in the global oilfield services market, its broad and technologically-complex product/service offerings, and its robust financial profile.
Get the full Analyst Report on HAL - FREE
Get the full Analyst Report on SLB - FREE